Thymmune Therapeutics
Manish Jain is an experienced biotechnology executive with a robust background in pharmaceutical sciences and technical operations. Presently serving as Chief Technology Officer at Thymmune Therapeutics and Avenge Bio, Manish Jain previously held various leadership roles at Genocea, including Vice President of Pharmaceutical Sciences & Manufacturing and Senior Director of CMC & Technical Operations. Manish Jain's career also includes significant positions at Momenta Pharmaceuticals and ImmunoGen, focusing on drug product development, manufacturing sciences, and process development. Academic credentials include a Master of Science in Chemical Engineering from the University of Virginia and a notable educational experience at Harvard Medical School.
This person is not in any teams
This person is not in any offices
Thymmune Therapeutics
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.